Mice Uterine Stem Cells are Affected by Neonatal Endocrine Disruption & Initiate Uteropathies in Adult Life Independent of Circulatory Ovarian Hormones

article OA: closed CC0 ⤵ 3 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-12

Neonatal endocrine disruption in mice altered uterine stem cells, causing uteropathies in adulthood independent of circulating ovarian hormones and dysregulating DNA repair mechanisms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This study examined whether developmental endocrine disruption alters uterine stem/progenitor cells to drive adult uteropathies. Mouse pups were exposed to estradiol or vehicle during postnatal days 3–7, then underwent bilateral ovariectomy at day 30 and received sequential estradiol/progesterone to induce a receptive uterus in controls; despite similar later hormonal exposure, endocrine disruption produced a non-receptive uterus with endometrial and myometrial hyperplasia, elevated stem cell marker expression (Oct-4A/Oct-4, Sox2, Nanog), poorly formed glands, and “defective” epithelial progenitors disseminated into the myometrium and blood vessels. The paper reports progesterone resistance and estradiol dominance via downregulation of Erα/Pr and upregulation of Erβ transcripts, alongside dysregulation of DNA mismatch repair/repair-axis transcripts and increased Ki67, which it interprets as genomic instability. A key caveat is that the mechanistic conclusions derive from marker and lesion analyses rather than direct functional lineage evidence. This paper is centrally about endometriosis — it links defective uterine epithelial progenitors arising from neonatal endocrine disruption to epithelial invasion/mobilization patterns consistent with initiation of endometriosis (and also adenomyosis) in adult life.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

It is generally believed that ovarian hormones regulate uterine functions and their altered levels result in various uteropathies like non-receptive uterus, endometrial hyperplasia, adenomyosis, endometriosis, leiomyomas and cancer. Uterus harbors two populations of stem cells including pluripotent, very small embryonic-like stem cells (VSELs) and tissue-specific progenitors (endometrial stem cells, EnSCs). Unlike endometrial mesenchymal stem/ stromal cells, VSELs/EnSCs express ERα, ERβ and PR which makes them directly vulnerable to perinatal endocrine insults. Present study was undertaken to evaluate whether uteropathies occur due to altered hormones and/or intrinsic changes in stem/progenitor cells. Mice pups, exposed to estradiol (20 µg/pup/day) on postnatal days 3-7 or vehicle, were subjected to bilateral ovariectomy on day 30 and later exposed sequentially to estradiol and progesterone resulting in receptive uterus in control mice. Despite similar hormonal exposure, endocrine disruption resulted in non-receptive uterus with noticeable endometrial and myometrial hyperplasia and up-regulation of stem cell markers (Oct-4A, Oct-4, Sox2, Nanog). Glands were poorly formed and 'defective' epithelial progenitors were found disseminated into myometrium and blood vessels revealing how adenomyosis and endometriosis possibly initiate. Progesterone resistance and estradiol dominance due to downregulation of Erα & Pr and upregulation of Erβ transcripts was observed in both intact uterus and stem cells enriched from uterus. Transcripts specific for DNA mismatch repair axis (Pcna, NP95 and Dnmt1), repair enzymes (Brca-1, Rad51 and Mlh1) were dysregulated whereas Ki67 was ten-folds increased suggestive of genomic instability. Study reveals role of stem cells in initiating uteropathies during adult life independent of circulatory ovarian hormones. Endocrine disruption affects tissue resident stem/progenitor cells (VSELs/EnSCs) in both endometrium and myometrium, result in epithelial cells hyperplasia, non-receptive endometrium, adenomyosis and defective stem cells and epithelial progenitors were detected in the perimetrium from where they can mobilize to ectopic sites to initiate endometriosis. Study shows stem cell basis for various uteropathies. VSEL: Very small embryonic like stem cell; EnSC: Endometrial stem cell; E + P: Estradiol + Progesterone; E: Endometrium; P: Perimetrium; M: Myometrium; ACD: Asymmetrical cell division; SCD: Symmetrical cell division; CE: Clonal expansion; G: Gland; S: Stromal cell; US: Undifferentiated stromal cell; LE: Luminal epithelium; GE: Glandular epithelium; EP: Epithelial progenitors; SMC: Spindle-shaped myometrial cell; OMC: Oval-shaped myometrial cell.
Full text 19,442 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

It is generally believed that ovarian hormones regulate uterine functions and their altered levels result in various uteropathies like non-receptive uterus, endometrial hyperplasia, adenomyosis, endometriosis, leiomyomas and cancer. Uterus harbors two populations of stem cells including pluripotent, very small embryonic-like stem cells (VSELs) and tissue-specific progenitors (endometrial stem cells, EnSCs). Unlike endometrial mesenchymal stem/ stromal cells, VSELs/EnSCs express ERα, ERβ and PR which makes them directly vulnerable to perinatal endocrine insults. Present study was undertaken to evaluate whether uteropathies occur due to altered hormones and/or intrinsic changes in stem/progenitor cells. Mice pups, exposed to estradiol (20 µg/pup/day) on postnatal days 3–7 or vehicle, were subjected to bilateral ovariectomy on day 30 and later exposed sequentially to estradiol and progesterone resulting in receptive uterus in control mice. Despite similar hormonal exposure, endocrine disruption resulted in non-receptive uterus with noticeable endometrial and myometrial hyperplasia and up-regulation of stem cell markers (Oct-4A, Oct-4, Sox2, Nanog). Glands were poorly formed and ‘defective’ epithelial progenitors were found disseminated into myometrium and blood vessels revealing how adenomyosis and endometriosis possibly initiate. Progesterone resistance and estradiol dominance due to downregulation of Erα & Pr and upregulation of Erβ transcripts was observed in both intact uterus and stem cells enriched from uterus. Transcripts specific for DNA mismatch repair axis (Pcna, NP95 and Dnmt1), repair enzymes (Brca-1, Rad51 and Mlh1) were dysregulated whereas Ki67 was ten-folds increased suggestive of genomic instability. Study reveals role of stem cells in initiating uteropathies during adult life independent of circulatory ovarian hormones. Graphical Abstract Endocrine disruption affects tissue resident stem/progenitor cells (VSELs/EnSCs) in both endometrium and myometrium, result in epithelial cells hyperplasia, non-receptive endometrium, adenomyosis and defective stem cells and epithelial progenitors were detected in the perimetrium from where they can mobilize to ectopic sites to initiate endometriosis. Study shows stem cell basis for various uteropathies. VSEL: Very small embryonic like stem cell; EnSC: Endometrial stem cell; E + P: Estradiol + Progesterone; E: Endometrium; P: Perimetrium; M: Myometrium; ACD: Asymmetrical cell division; SCD: Symmetrical cell division; CE: Clonal expansion; G: Gland; S: Stromal cell; US: Undifferentiated stromal cell; LE: Luminal epithelium; GE: Glandular epithelium; EP: Epithelial progenitors; SMC: Spindle-shaped myometrial cell; OMC: Oval-shaped myometrial cell Similar content being viewed by others Data availability Supplementary section provides additional data. Code availability Not applicable.

References

Marquardt, R. M., Kim, T. H., Shin, J.-H., & Jeong, J. W. (2019). Progesterone and estrogen signaling in the endometrium: What goes wrong in endometriosis? International Journal of Molecular Sciences, 20(15), 3822. https://doi.org/10.3390/ijms20153822 Montgomery, G. W., Mortlock, S., & Giudice, L. C. (2020). Should genetics now be considered the pre-eminent etiologic factor in endometriosis? Journal of Minimally Invasive Gynecology, 27(2), 280–286. https://doi.org/10.1016/j.jmig.2019.10.020 Andaloussi, A. E., Al-Hendy, A., Ismail, N., Boyer, T. G., & Halder, S. K. (2020). Introduction of somatic mutation in MED12 induces Wnt4/β-catenin and disrupts autophagy in human uterine myometrial cell. Reproductive Sciences, 27(3), 823–832. https://doi.org/10.1007/s43032-019-00084-7 Newbold, R. R., Bullock, B. C., & McLachlan, J. A. (1990). Uterine adenocarcinoma in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis. Cancer Research, 50, 7677–7681. Newbold, R. R., Jefferson, W. N., & Padilla-Banks, E. (2009). Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environmental Health Perspectives, 117(6), 879–885. https://doi.org/10.1289/ehp.0800045 Suen, A. A., Jefferson, W. N., Williams, C. J., & Wood, C. E. (2018). Differentiation patterns of uterine carcinomas and precursor lesions induced by neonatal estrogen exposure in mice. Toxicologic Pathology, 46(5), 574–596. https://doi.org/10.1177/0192623318779326 Fernung, L. E. P., Yang, Q., Sakamuro, D., Kumari, A., Mas, A., & Al-Hendy, A. (2018). Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells†. Biology of Reproduction. https://doi.org/10.1093/biolre/ioy097 Signorile, P. G., Spugnini, E. P., Mita, L., Mellone, P., D’Avino, A., Bianco, M., … Baldi, A. (2010). Pre-natal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring. General and Comparative Endocrinology, 168(3), 318–325. https://doi.org/10.1016/j.ygcen.2010.03.030 Filby, C. E., Rombauts, L., Montgomery, G. W., Giudice, L. C., & Gargett, C. E. (2020). Cellular origins of endometriosis: Towards novel diagnostics and therapeutics. Seminars in Reproductive Medicine, 38(02/03), 201–215. https://doi.org/10.1055/s-0040-1713429 Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., et al. (2019). Endometriosis. Endocrine Reviews, 40(4), 1048–1079. https://doi.org/10.1210/er.2018-00242 Simoni, M., & Taylor, H. S. (2018). Therapeutic strategies involving uterine stem cells in reproductive medicine. Current Opinion in Obstetrics & Gynecology, 30(3), 209–216. https://doi.org/10.1097/gco.000000000000045 Bulun, S. E. (2013). Uterine fibroids. New England Journal of Medicine, 369(14), 1344–1355. https://doi.org/10.1056/nejmra1209993 Kim, J. J., Kurita, T., & Bulun, S. E. (2013). Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocrine Reviews, 34(1), 130–162. https://doi.org/10.1210/er.2012-1043 Cousins, F. L., Pandoy, R., Jin, S., & Gargett, C. E. (2021). The elusive endometrial epithelial stem/progenitor cells.Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.640319 Santamaria, X., Mas, A., Cervelló, I., Taylor, H., & Simon, C. (2018). Uterine stem cells: From basic research to advanced cell therapies. Human Reproduction Update, 24(6), 673–693. https://doi.org/10.1093/humupd/dmy028 Cousins, F. L., O, D. F., & Gargett, C. E. (2018). Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis. Best Practice & Research Clinical Obstetrics & Gynaecology, 50, 27–38. https://doi.org/10.1016/j.bpobgyn.2018.01.011 Chan, R. W. S., Ng, E. H. Y., & Yeung, W. S. B. (2011). Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. The American Journal of Pathology, 178(6), 2832–2844. https://doi.org/10.1016/j.ajpath.2011.02.025 Li, J., Dai, Y., Zhu, H., Jiang, Y., & Zhang, S. (2016). Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1. Human Reproduction, 31(6), 1224–1235. https://doi.org/10.1093/humrep/dew058 Szukiewicz, D., Stangret, A., Ruiz-Ruiz, C., Olivares, E. G., Soriţău, O., Suşman, S., & Szewczyk, G. (2021). Estrogen- and progesterone (P4)-mediated epigenetic modifications of endometrial stromal cells (EnSCs) and/or mesenchymal stem/stromal cells (MSCs) in the etiopathogenesis of endometriosis. Stem Cell Reviews and Reports, 17(4), 1174–1193. https://doi.org/10.1007/s12015-020-10115-5 Mas, A., Cervelló, I., Gil-Sanchis, C., Faus, A., Ferro, J., Pellicer, A., & Simón, C. (2012). Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells. Fertility and Sterility, 98(3). https://doi.org/10.1016/j.fertnstert.2012.04.044 Ono, M., Qiang, W., Serna, V. A., Yin, P., Coon, J. S., Navarro, A., et al. (2012). Role of stem cells in human uterine leiomyoma growth. PLoS ONE, 7(5). https://doi.org/10.1371/journal.pone.0036935 Barragan, F., Irwin, J. C., Balayan, S., Erikson, D. W., Chen, J. C., Houshdaran, S., et al. C. (2016). Human endometrial fibroblasts derived from mesenchymal progenitors inherit progesterone resistance and acquire an inflammatory phenotype in the endometrial niche in endometriosis. Biology of Reproduction, 94(5). https://doi.org/10.1095/biolreprod.115.136010 Caplan, A. I. (2017). Mesenchymal stem cells: Time to change the name! STEM CELLS Translational Medicine, 6(6), 1445–1451. https://doi.org/10.1002/sctm.17-0051 Bhartiya, D. (2016). An update on endometrial stem cells and progenitors. Human Reproduction Update, 22(4), 529–530. https://doi.org/10.1093/humupd/dmw010 Syed, S. M., Kumar, M., Ghosh, A., Tomasetig, F., Ali, A., Whan, R. M., … Tanwar, P. S. (2020). Endometrial Axin2 cells drive epithelial homeostasis, regeneration, and cancer following oncogenic transformation. Cell Stem Cell, 26(1). https://doi.org/10.1016/j.stem.2019.11.012 Syed, S. M., & Tanwar, P. S. (2020). Axin2 endometrial stem cells: The source of endometrial regeneration and cancer. Molecular & Cellular Oncology, 7(3), 1729681. https://doi.org/10.1080/23723556.2020.1729681 Ghosh, A., Syed, S. M., Kumar, M., Carpenter, T. J., Teixeira, J. M., Houairia, N., et al. (2020). In vivo cell fate tracing provides no evidence for mesenchymal to epithelial transition in adult fallopian tube and uterus. Cell Reports, 31(6), 107631. https://doi.org/10.1016/j.celrep.2020.107631 Singh, P., & Bhartiya, D. (2020). Pluripotent stem (VSELs) and progenitor (EnSCs) cells exist in adult mouse uterus and show cyclic changes across estrus cycle. Reproductive Sciences, 28(1), 278–290. https://doi.org/10.1007/s43032-020-00250-2 James, K., Bhartiya, D., Ganguly, R., Kaushik, A., Gala, K., Singh, P., Metkari, S. M. (2018). Gonadotropin and steroid hormones regulate pluripotent very small embryonic-like stem cells in adult mouse uterine endometrium. Journal of Ovarian Research, 11(1). https://doi.org/10.1186/s13048-018-0454-4 Bhartiya, D., & James, K. (2017). Very small embryonic-like stem cells (VSELs) in adult mouse uterine perimetrium and myometrium. Journal of Ovarian Research, 10(1). https://doi.org/10.1186/s13048-017-0324-5 Gunjal, P., Bhartiya, D., Metkari, S., Manjramkar, D., & Patel, H. (2015). Very small embryonic-like stem cells are the elusive mouse endometrial stem cells- a pilot study. Journal of Ovarian Research, 8(1). https://doi.org/10.1186/s13048-015-0138-2 Ratajczak, M. Z., Ratajczak, J., & Kucia, M. (2019). Very small embryonic-like stem cells (VSELs) An update and future directions. Circulation Research, 124(2), 208–210. https://doi.org/10.1161/circresaha.118.314287 Bhartiya, D., Shaikh, A., Anand, S., Patel, H., Kapoor, S., Sriraman, K., et al. (2016). Endogenous, very small embryonic-like stem cells: Critical review, therapeutic potential and a look ahead. Human Reproduction Update, 23(1), 41–76. https://doi.org/10.1093/humupd/dmw030 Shaikh, A., Nagvenkar, P., Pethe, P., Hinduja, I., & Bhartiya, D. (2015). Molecular and phenotypic characterization of CD133 and SSEA4 enriched very small embryonic-like stem cells in human cord blood. Leukemia, 29(9), 1909–1917. https://doi.org/10.1038/leu.2015.100 Bhartiya, D., Patel, H., Ganguly, R., Shaikh, A., Shukla, Y., Sharma, D., & Singh, P. (2018). Novel insights into adult and cancer stem cell biology. Stem Cells and Development, 27(22), 1527–1539. https://doi.org/10.1089/scd.2018.0118 Kaushik, A., Anand, S., & Bhartiya, D. (2020). Altered biology of testicular VSELs and SSCs by neonatal endocrine disruption results in defective spermatogenesis, reduced fertility and tumor initiation in adult mice. Stem Cell Reviews and Reports, 16(5), 893–908. https://doi.org/10.1007/s12015-020-09996-3 Chapman, J. C., Min, S. H., Freeh, S. M., & Michael, S. D. (2009). The estrogen-injected female mouse: new insight into the etiology of PCOS. Reproductive Biology and Endocrinology, 7(1). https://doi.org/10.1186/1477-7827-7-47 Uimari, O., Järvelä, I., & Ryynänen, M. (2011). Do symptomatic endometriosis and uterine fibroids appear together? Journal of Human Reproductive Sciences, 4(1), 34. https://doi.org/10.4103/0974-1208.82358 Gebril, M., Hirota, Y., Aikawa, S., Fukui, Y., Kaku, T., Matsuo, M., et al. (2020). Uterine epithelial progesterone receptor governs uterine receptivity through epithelial cell differentiation. Endocrinology, 161(12). https://doi.org/10.1210/endocr/bqaa195 Fukui, Y., Hirota, Y., Matsuo, M., Gebril, M., Akaeda, S., Hiraoka, T., & Osuga, Y. (2019). Uterine receptivity, embryo attachment, and embryo invasion: Multistep processes in embryo implantation. Reproductive Medicine and Biology, 18(3), 234–240. https://doi.org/10.1002/rmb2.12280 Hirota, Y. (2019). Progesterone governs endometrial proliferation-differentiation switching and blastocyst implantation. Endocrine Journal, 66(3), 199–206. https://doi.org/10.1507/endocrj.ej18-0431 Johnatty, S. E., Stewart, C. J. R., Smith, D., Nguyen, A., Dwyer, J. O., O’Mara, T. A., et al. (2020). Co-existence of leiomyomas, adenomyosis and endometriosis in women with endometrial cancer. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-59916-1 Wang, Y., Nicholes, K., & Shih, I.-M. (2020). The origin and pathogenesis of endometriosis. Annual Review of Pathology: Mechanisms of Disease, 15(1), 71–95. https://doi.org/10.1146/annurev-pathmechdis-012419-032654 Chantalat, E., Valera, M.-C., Vaysse, C., Noirrit, E., Rusidze, M., Weyl, A., et al. (2020). Estrogen receptors and endometriosis. International Journal of Molecular Sciences, 21(8), 2815. https://doi.org/10.3390/ijms21082815 Genc, M., Genc, B., & Cengiz, H. (2014). Adenomyosis and accompanying gynecological pathologies. Archives of Gynecology and Obstetrics, 291(4), 877–881. https://doi.org/10.1007/s00404-014-3498-8 Kok, V. C., Tsai, H.-J., Su, C.-F., & Lee, C.-K. (2015). The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: A population-based study. International Journal of Gynecologic Cancer, 25(6), 968–976. https://doi.org/10.1097/igc.0000000000000454 Verit, F. F., & Yucel, O. (2013). Endometriosis, leiomyoma and adenomyosis: The risk of gynecologic malignancy. Asian Pacific Journal of Cancer Prevention, 14(10), 5589–5597. https://doi.org/10.7314/apjcp.2013.14.10.5589 Maruyama, S., Imanaka, S., Nagayasu, M., Kimura, M., & Kobayashi, H. (2020). Relationship between adenomyosis and endometriosis; Different phenotypes of a single disease? European Journal of Obstetrics & Gynecology and Reproductive Biology, 253, 191–197. https://doi.org/10.1016/j.ejogrb.2020.08.019 Yilmaz, B. D., & Bulun, S. E. (2019). Endometriosis and nuclear receptors. Human Reproduction Update, 25(4), 473–485. https://doi.org/10.1093/humupd/dmz005 Yovich, J. L., Rowlands, P. K., Lingham, S., Sillender, M., & Srinivasan, S. (2020). Pathogenesis of endometriosis: Look no further than John Sampson. Reproductive Bio Medicine Online, 40(1), 7–11. https://doi.org/10.1016/j.rbmo.2019.10.007 Guo, Y., Schaik, T. V., Jhamat, N., Niazi, A., Chanrot, M., Charpigny, G., et al. (2019). Differential gene expression in bovine endometrial epithelial cells after challenge with LPS; specific implications for genes involved in embryo maternal interactions. Plos One, 14(9). https://doi.org/10.1371/journal.pone.0222081 Ikhena, D. E., & Bulun, S. E. (2017). Literature review on the role of uterine fibroids in endometrial function. Reproductive Sciences, 25(5), 635–643. https://doi.org/10.1177/1933719117725827 Mas, A., Stone, L., O’connor, P. M., Yang, Q., Kleven, D., Simon, C., et al. (2016). Developmental exposure to endocrine disruptors expands murine myometrial stem cell compartment as a prerequisite to leiomyoma tumorigenesis. Stem Cells, 35(3), 666–678. https://doi.org/10.1002/stem.2519 Łupicka, M., Socha, B., Szczepańska, A., & Korzekwa, A. (2015). Expression of pluripotency markers in the bovine uterus with adenomyosis. Reproductive Biology and Endocrinology, 13(1). https://doi.org/10.1186/s12958-015-0106-0 Cardoso, J. V., Perini, J. A., Machado, D. E., Pinto, R., & Medeiros, R. (2020). Systematic review of genome-wide association studies on susceptibility to endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 255, 74–82. https://doi.org/10.1016/j.ejogrb.2020.10.017 Moore, L., Leongamornlert, D., Coorens, T. H. H., Sanders, M. A., Ellis, P., Dentro, S. C., et al. (2020). The mutational landscape of normal human endometrial epithelium. Nature, 580(7805), 640–646. https://doi.org/10.1038/s41586-020-2214-z Bae-Jump, V. (2020). Unraveling the mystery of clear cell endometrial cancer. Gynecologic Oncology, 158(1), 1–2. https://doi.org/10.1016/j.ygyno.2020.06.159 Kyo, S., Sato, S., & Nakayama, K. (2020). Cancer-associated mutations in normal human endometrium: Surprise or expected? Cancer Science, 111(10), 3458–3467. https://doi.org/10.1111/cas.14571 Jin, S. (2019). Bipotent stem cells support the cyclical regeneration of endometrial epithelium of the murine uterus. Proceedings of the National Academy of Sciences, 116(14), 6848–6857. https://doi.org/10.1073/pnas.1814597116 Owusu-Akyaw, A., Krishnamoorthy, K., Goldsmith, L. T., & Morelli, S. S. (2018). The role of mesenchymal–epithelial transition in endometrial function. Human Reproduction Update, 25(1), 114–133. https://doi.org/10.1093/humupd/dmy035

Acknowledgements

Help from Praveen, Swati and Shobha from central facilities at NIRRH is acknowledged. Funding Funding support for the study was provided to DB by Indian Council of Medical Research, Government of India, New Delhi. PS acknowledges DST-INSPIRE fellowship (IF170144). Author information Authors and Affiliations Contributions DB designed the study, data interpretation, manuscript preparation. PS performed all experiments, data interpretation and manuscript preparation. SMM helped with surgeries. All authors read and approved final draft of manuscript. Corresponding author Ethics declarations Ethics approval The study was approved by Institute Animal Ethics Committee (IAEC). Consent to participate Not applicable. Consent for publication Institute accession number is RA/1045/03–2021. Conflicts of interest/Competing interests Authors declare no conflict of interest whatsoever. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This article belongs to the Topical Collection: Special Issue on Tissue-resident Stem/Progenitor Cells Endowed with Broader Germ Layer Specification Potential in Normal and Cancerous Tissues Guest Editor: Deepa Bhartiya Supplementary Information Below is the link to the electronic supplementary material. Rights and permissions About this article Cite this article Singh, P., Metkari, S.M. & Bhartiya, D. Mice Uterine Stem Cells are Affected by Neonatal Endocrine Disruption & Initiate Uteropathies in Adult Life Independent of Circulatory Ovarian Hormones. Stem Cell Rev and Rep 18, 1686–1701 (2022). https://doi.org/10.1007/s12015-021-10279-8 Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s12015-021-10279-8

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Adenomyosis Endometriosis Animals Embryonic Stem Cells Estradiol Estrogen Receptor alpha Estrogen Receptor alpha Estrogen Receptor beta Female Humans Hyperplasia Mice Pregnancy Progesterone Uterus

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (60)

Cited by (3)

Source provenance

europepmc
last seen: 2026-08-19T06:08:28.815611+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:24:14.728497+00:00
unpaywall
last seen: 2026-08-19T06:23:00.919175+00:00
License: CC0 · commercial use OK